Kim Tsoi, MD, PhD

Kim Tsoi, MD, PhD

Lunenfeld-Tanenbaum Research Institute,
Sinai Health System

Development of a Nanoparticle-Based Approach to Treat Lung Metastases in Soft Tissue Sarcoma

Soft tissue sarcomas (STS) are a rare, aggressive type of cancer that arises from connective tissue. While the primary tumour is controlled with radiation and surgery, half of patients develop metastases and are incurable.  Sarcomas are unique as most metastases occur in the lung.

Her work will develop a treatment for soft tissue sarcomas (STS) by examining which immune cells are present in lung metastases and contribute to disease and using nanotechnology to develop a therapy to target those cells. Ultimately, the study aims to improve our understanding of metastatic STS and introduce a new method for its treatment.

Recipient of a Banting-Mitacs Discovery Award.